Skip to main content

N-of-One to Support Oncology Testing at BloodCenter of Wisconsin

NEW YORK (GenomeWeb) – N-of-One said today that the BloodCenter of Wisconsin has selected it to provide interpretation services for HemeOnc, a next-generation sequencing-based panel developed by the not-for-profit organization for the diagnosis, prognosis, and risk stratification of hematologic malignancies.

"BloodCenter of Wisconsin selected N-of-One because of their high quality clinical interpretation which addresses the specific features of each patient’s molecular profile," D. P. Dash, director of the molecular oncology laboratory at BloodCenter of Wisconsin, said in a statement. BloodCenter's diagnostic laboratories offer molecular testing for diagnostic and prognostic markers within acute myeloid leukemia, myeloproliferative neoplasms, and chronic myelogenous leukemia. Its test menus are built around testing algorithms that are recommended by peer-reviewed treatment guidelines such as the National Comprehensive Cancer Network and World Health Organization.

N-of-One provides clinical interpretation that is scalable and cost-effective, as well as patient-specific, it said.

Financial and other terms of the agreement were not disclosed.


The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.